Associate Director, Performance Reporting, Dashboards & Visualization

Associate Director, Performance Reporting, Dashboards & Visualization Employer Legend Biotech Location Bridgewater, New Jersey Salary $193629 - $254137 Start date May 11, 2026 View more categories View less categories Discipline Information Technology , Business/Data Analytics , Marketing , Market Research/Customer Experience , Sales & Service Required Education Bachelors Degree Position Type Full time Apply now Save job Click to add the job to your shortlist You need to sign in or create an account to save a job. Send job Job Details Company Job Details Legend Biotech is a global biotechnology company dedicated to treating, and one day curing, life-threatening diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R D sites around the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide. Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel (cilta-cel). Our strategic partnership is designed to combine the strengths and expertise of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma. Legend Biotech is seeking an Associate Director, Performance Reporting, Dashboards & Visualization as part of the CAR-T Operations team based in Bridgewater, NJ. Role Overview Performance Reporting, Dashboards & Visualization at Legend enable commercial decision-making through integrated data, intuitive visualization, and scalable performance management solutions. This role serves as the strategic owner of business performance reporting and customer coverage insights, ensuring leaders and field teams have timely, actionable views into execution, reach, and impact. The Associate Director will lead the evolution of dashboards and reporting products, partner closely with commercial stakeholders to translate business priorities into analytics solutions, and leverage AI-enabled capabilities to modernize reporting, improve self-service, and accelerate insight delivery. This role focuses on performance measurement, visualization, and reporting enablement, operating in close partnership with Sales Force Effectiveness and Advanced Analytics teams who own optimization and prescriptive decision support. Key Responsibilities Business Performance Own enterprise performance reporting, ensuring consistent, trusted views into commercial execution across Activated Centers and the community. Integrate multiple pharmaceutical data sources (e.g., sales, claims, engagement, and research data) to deliver comprehensive, descriptive insights into customer activity and patient dynamics across the disease journey. Partner with Commercial, Marketing, and SFE teams to align on KPI definitions and reporting standards, serving as the single point of ownership for how performance and coverage are measured and visualized. Dashboards, Visualization & Reporting Products Lead the design, delivery, and evolution of dashboards and reporting products, ensuring clarity, usability, and consistency for executive, field, and operational audiences. Translate business questions into intuitive visual analytics, enabling stakeholders to quickly understand performance trends, coverage patterns, and execution status without requiring additional analysis. Establish visualization and reporting best practices, improving storytelling, consistency, and interpretability across all performance reporting assets. AI-Enabled Reporting & Automation Leverage AI-enabled capabilities to modernize reporting and dashboards, including: Automated data refreshes and quality checks Intelligent alerts for material performance changes AI-generated summaries to accelerate interpretation of dashboard outputs Drive automation of recurring reporting processes, reducing manual effort, improving reliability, and shortening time-to-insight for leadership and field teams. Continuously evolve the reporting ecosystem to keep pace with business needs while maintaining clarity of ownership and role boundaries. Decision Making Will work independently to make decisions related to technical direction, methodologies, approaches on how to address key business questions. Strong collaboration with cross functional teams and robust alignment with Manager will be needed in the identification of Key Business Questions and priorities. Requirements Master's degree (preferred) or Bachelor's degree in Business, Analytics, Economics, Data Science, or related field; advanced degree preferred. 8-12+ years of experience in pharmaceutical or life sciences analytics, with a strong focus on business performance reporting, dashboards, and visualization. Demonstrated experience operating at an associate director level, owning reporting products used by leadership and field teams. Deep expertise in commercial performance reporting, KPI frameworks, and customer coverage visibility. Strong understanding of pharmaceutical data sources (sales, claims, engagement, market research) from a reporting and insights perspective. AI-Enabled Reporting & Automation Proven ability to automate recurring reporting processes and scale self-service analytics while maintaining data quality and governance. Comfort partnering with Advanced Analytics teams to operationalize outputs into dashboards, without owning model development. Leadership & Communication Strong ability to translate complex data into clear, decision-ready insights for senior leadership. Excellent written and verbal communication skills, with experience delivering executive-level presentations. Proven cross-functional collaborator, partnering effectively with Commercial, Marketing, Sales Force Effectiveness, IT, and Data Engineering teams. Advanced proficiency in data visualization and dashboarding tools (e.g., Power BI or equivalent), with a strong emphasis on clarity, usability, and executive storytelling. Experience leveraging AI-enabled capabilities to enhance reporting efficiency and insight delivery (e.g., automated alerts, summaries, anomaly highlighting). #Li-JK1 #Li-Hybrid The base pay range below is what Legend Biotech USA Inc. reasonably expects to offer at the time of posting. Actual compensation may vary based on experience, skills, qualifications, and geographic location. The company reserves the right to modify this range as needed and in accordance with applicable laws.

Other Types of Pay:

Performance-based bonus and/or equity is available to employees in eligible roles.

Benefits and Paid Time Off:

Medical, dental, and vision insurance as well as a 401(k) retirement plan with a company match that vests fully on day one. We offer eight (8) weeks of paid parental leave after just three (3) months of employment, and a paid time off policy that includes vacation time, personal time, sick time, floating holidays, and eleven (11) company holidays. Additional voluntary benefits include flexible spending and health savings accounts, life and AD&D insurance, short- and long-term disability coverage, legal assistance, and supplemental plans such as pet, critical illness, accident, and hospital indemnity insurance. We also provide voluntary commuter benefits, family planning and care resources, well-being initiatives, and peer-to-peer recognition programs; demonstrating our ongoing commitment to building a culture where our people feel empowered, supported, and inspired to do their best work. Pay Range (Base Pay): $193,629 - $254,137 USD Please note: These benefits are offered exclusively to permanent full-time employees. Contractors are not eligible for benefits through Legend Biotech. EEO Statement It is the policy of Legend Biotech to provide equal employment opportunities without regard to actual or perceived race, color, creed, religion, national origin, ancestry, citizenship status, age, sex or gender (including pregnancy, childbirth, related medical conditions and lactation), gender identity or gender expression (including transgender status), sexual orientation, marital status, military service and veteran status, disability, genetic information, or any other protected characteristic under applicable federal, state or local laws or ordinances. Employment is at-will and may be terminated at any time with or without cause or notice by the employee or the company. For information related to our privacy notice, please review: Legend Biotech Privacy Notice . Company Legend Biotech was founded as an early-stage cell therapy company in 2014. The company was the brainchild of visionary scientists who recognized that antibody-based therapeutics could potentially treat disease and possessed the backgrounds in immunology and gene editing to take the leap. For two years, Legend Biotech, then known as the "Legend Project," operated in a room the size of a freight elevator, with the goal of creating a cell therapy for multiple myeloma, a hematological cancer that often relapses and can become refractory. The team produced nanobodies for single-domain antibody drugs and ultimately extended the half-life of the nanobodies with proprietary technologies. In 2015, Legend's scientists focused on research for chimeric antigen-receptor T-cells (CAR-T) targeting the BCMA protein, making the biotech one of the first companies in the world to engineer CAR-T cells for the BCMA protein. In 2016, investigator-initiated trials began in China. In 2017, data from the trials were presented at the American Society for Clinical Oncology (ASCO), which led to a partnership with biopharmaceutical company Janssen Biotech, Inc. to co-develop the anti-BCMA CAR-T, ciltacabtagene autoleucel (cilta-cel). Applications seeking approval of cilta-cel for the treatment of patients with RRMM are currently under regulatory review by several health authorities around the world.

CARVYKTI

™ (ciltacabtagene autoleucel) was approved by the U.S. Food and Drug Administration in February 2022 and received conditional marketing approval from the European Medicines Agency in May 2022. Today Legend Biotech is a global, commercial-stage company driven by a passion for patients. We continue to build our pipeline of cell therapy platforms, which includes CAR-T, CAR-NK, CAR-γδ T and non-gene-editing CAR technologies. Our goal is to bring hope and opportunity to patients and their families by continuing to explore unique technologies. Company info Location Somerset New Jersey United States Share this job Facebook Twitter LinkedIn Apply now Send job Apply now Save job Click to add the job to your shortlist You need to sign in or create an account to save a job. Get job alerts Create a job alert and receive personalized job recommendations straight to your inbox. Create alert